Liu, Sixue
Dharanipragada, Prashanthi
Lomeli, Shirley H. http://orcid.org/0000-0002-0872-8309
Wang, Yan
Zhang, Xiao http://orcid.org/0000-0003-1706-2868
Yang, Zhentao
Lim, Raymond J.
Dumitras, Camelia
Scumpia, Philip O. http://orcid.org/0000-0002-2563-2042
Dubinett, Steve M. http://orcid.org/0000-0003-3656-8039
Moriceau, Gatien
Johnson, Douglas B. http://orcid.org/0000-0002-6390-773X
Moschos, Stergios J.
Lo, Roger S. http://orcid.org/0000-0002-5337-5004
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Center for Information Technology (1R01CA176111A1, 1R21CA215910-01, R21CA255837-01, 1P01CA168585)
Melanoma Research Alliance (Team Science Award, Dermatology Fellowship, Dermatology Fellowship, Dermatology Fellowship, Young Investigator Award)
Merck & Co., Inc. | Merck Sharp and Dohme (OTSP, OTSP)
Melanoma Research Foundation (Career Development Award)
Article History
Received: 23 April 2022
Accepted: 14 March 2023
First Online: 27 April 2023
Competing interests
: R.S.L. reports research support from Merck and OncoSec, clinical trial support from Pfizer and Bristol Myers Squibb, honorarium from Pfizer and US Patent Application Serial No. 63/488,609. S.J.M. reports research support from Merck, Amgen and SYNDAX and consultant work for EMD Serono and iTeos Therapeutics. D.B.J. reports research support from Bristol Myers Squibb and Incyte and consultant work for Bristol Myers Squibb, Catalyst, Iovance, Jansen, Mallinckrodt, Merck, Mosaic, Novartis, Oncosec, Pfizer and Targovax. S.M.D. reports service on scientific advisory boards for LungLife AI and Early Diagnostics. P.O.S. reports research support from Castle Biosciences, advisory board service for Castle Biosciences and being a co-founder and shareholder of Tempo Therapeutics. The remaining authors declare no competing interests.